NOVALGEN LIMITED

11621264
Active Northwood Hills

Research and experimental development on biotechnology

8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
N

NOVALGEN LIMITED

11621264

Research and experimental development on biotechnology

Founded 14 Oct 2018 Active Northwood Hills, England 8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

IMMUNOCURE LIMITED 14 Oct 2018 — 6 Nov 2018
Accounts Due 30 Sept 2026 3 months remaining
Confirmation
Net assets £4M £334K 2025 year on year
Total assets £5M £249K 2025 year on year
Total Liabilities £1M £583K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Argyle House Level 3 Northside Joel Street Northwood Hills Middlesex HA6 1NW England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for NOVALGEN LIMITED (11621264), an active life sciences and medical technology company based in Northwood Hills, England. Incorporated 14 Oct 2018. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2019–2025)

Cash in Bank

£1.37M

Increased by £686.55k (+100%)

Net Assets

£3.53M

Decreased by £333.57k (-9%)

Total Liabilities

£1.37M

Increased by £582.82k (+74%)

Turnover

N/A

Employees

8

Decreased by 7 (-47%)

Debt Ratio

28%

Increased by 11 (+65%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Dec Year End
2024
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3
Grants 1

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jan 2019Seed, Series A
Investor 2Jan 2019Seed, Series A
Investor 5Jan 2019Series A

Share Capital

Share Capital

Share allotments and capital structure

64 Allotments 16,815,224 Shares £16.63m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 May 202650,000£50k£1
20 May 202650,000£50k£1
14 May 202655,695£0£0
11 May 202611,042£11k£1
6 May 2026100,000£100k£1

Officers

Officers

1 active 2 resigned
Status
Amit Chunilal NathwaniDirectorBritishEngland656 Jan 2020Active

Shareholders

Shareholders (24)

Convergys Capital Limited
37.2%
11,750,000
Convergys Capital Limited
37.2%
11,750,000

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased

Convergys Capital Limited

Unknown

Active
Notified 31 May 2019
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Ghl Capital Ltd

Unknown

Active
Notified 22 Jan 2026
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Amit Chunilal Nathwani

Ceased 20 Mar 2020

Ceased

Ucl Business Plc

Ceased 16 Aug 2019

Ceased

Group Structure

Group Structure

NOVALGEN LIMITED Current Company
BI8 LIMITED united kingdom
NOVALGEN NEWCO LIMITED united kingdom
NEXTGEN CAR LIMITED united kingdom
NVG-ENGAGER LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Jun 2026MiscellaneousReplacement filing of SH01 - 06/05/26 Statement of Capital gbp 214.171820
17 Jun 2026CapitalAllotment of shares (GBP 214.38224) on 11 May 2026
17 Jun 2026CapitalAllotment of shares (GBP 214.38224) on 21 May 2026
17 Jun 2026CapitalAllotment of shares (GBP 214.38224) on 20 May 2026
10 Jun 2026CapitalAllotment of shares (GBP 214.17182) on 14 May 2026
22 Jun 2026 Miscellaneous

Replacement filing of SH01 - 06/05/26 Statement of Capital gbp 214.171820

17 Jun 2026 Capital

Allotment of shares (GBP 214.38224) on 11 May 2026

17 Jun 2026 Capital

Allotment of shares (GBP 214.38224) on 21 May 2026

17 Jun 2026 Capital

Allotment of shares (GBP 214.38224) on 20 May 2026

10 Jun 2026 Capital

Allotment of shares (GBP 214.17182) on 14 May 2026

Recent Activity

Latest Activity

Replacement filing of SH01 - 06/05/26 Statement of Capital gbp 214.171820

4 days ago on 22 Jun 2026

Allotment of shares (GBP 214.38224) on 11 May 2026

1 weeks ago on 17 Jun 2026

Allotment of shares (GBP 214.38224) on 21 May 2026

1 weeks ago on 17 Jun 2026

Allotment of shares (GBP 214.38224) on 20 May 2026

1 weeks ago on 17 Jun 2026

Allotment of shares (GBP 214.17182) on 14 May 2026

2 weeks ago on 10 Jun 2026